CA 125 in the diagnosis of pelvic masses.

[1]  B. Jasani,et al.  Antigen CA125 in tumor tissue and serum from patients with adenocarcinoma of the ovary. , 1988, Gynecologic oncology.

[2]  D. Villemain,et al.  [Determination of tumor marker CA 125 in the cancer of the ovary: comparison of immunoenzyme and immunoradiometry methods]. , 1988, Pathologie et biologie.

[3]  K. J. Murphy,et al.  Predictive Value of CA 125 for Ovarian Carcinoma in Patients Presenting With Pelvic Masses , 1987, Obstetrics and gynecology.

[4]  E. Lewis.  The Use and Abuse of Imaging in Gynecologic Cancer , 1987, Cancer.

[5]  V. Abeler,et al.  Evaluation of serum CA 125 levels in the monitoring of ovarian cancer , 1987, American journal of obstetrics and gynecology.

[6]  M. Shelley,et al.  The clinical value of serum CA125 levels in ovarian cancer patients receiving platinum therapy. , 1987, European journal of cancer & clinical oncology.

[7]  M. Nap,et al.  The value of tumour marker CA 125 in surgical pathology , 1987, Histopathology.

[8]  J. Niloff,et al.  The CA 125 assay as a predictor of clinical recurrence in epithelial ovarian cancer , 1986, American journal of obstetrics and gynecology.

[9]  K. Aihara,et al.  Immunohistochemical localization of CA 125 antigen in formalin-fixed paraffin sections of ovarian tumors with the use of Pronase. , 1986, American journal of clinical pathology.

[10]  R. Bast,et al.  Preoperative Evaluation of Serum CA 125 Levels in Patients With Primary Epithelial Ovarian Cancer , 1986, Obstetrics and gynecology.

[11]  R. Bast,et al.  A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer. , 1983, The New England journal of medicine.